Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 4116292)

Published in Cancer Res on September 01, 1972

Authors

K R McIntire, C L Vogel, G L Princler, I R Patel

Articles by these authors

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol (1999) 11.78

Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98

Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature (1994) 3.70

Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med (1971) 3.50

Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol (2001) 2.11

Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet (1970) 2.11

Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer (1971) 2.06

A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A (1996) 1.90

Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res (1975) 1.75

Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest (1997) 1.70

Immunochemical studies of the reaction between a mouse myeloma macroglobulin and dextrans. Biochemistry (1970) 1.68

Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia. Lancet (1972) 1.66

Liver cell dysplasia: a premalignant condition. J Clin Pathol (1973) 1.66

Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44

Immunological effects of BCG in malignant melanoma: two modes of administration compared. Ann Intern Med (1972) 1.43

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group. Cancer (1998) 1.41

Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J Biol Chem (2000) 1.37

The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci U S A (1995) 1.22

Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique. Cancer (1977) 1.18

Agouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice. Proc Natl Acad Sci U S A (1995) 1.18

Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer. N Engl J Med (1976) 1.17

Kaposi's sarcoma: a comparison of classical, endemic, and epidemic forms. Semin Oncol (1984) 1.16

Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial. Int J Cancer (1971) 1.16

Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial. Oncology (2002) 1.15

Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Physicians (1998) 1.14

Ultrastructure of the gamma M immunoglobulin-molecule. J Mol Biol (1970) 1.11

Hepatitis-associated antigen and antibody in hepatocellular carcinoma: results of a continuing study. J Natl Cancer Inst (1972) 1.11

Abnormal serum immunoglobulins occurring with reticular neoplasms in a inbred strain of mouse. J Natl Cancer Inst (1967) 1.10

Pneumocystis carinii pneumonia. Ann Intern Med (1968) 1.10

Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst (1977) 1.10

A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group. Cancer (1997) 1.09

A review of vinorelbine in the treatment of breast cancer. Clin Breast Cancer (2001) 1.09

alpha-fetoprotein in noneoplastic hepatic disorders. JAMA (1975) 1.09

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States. Cancer (1977) 1.08

Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4. J Virol (1991) 1.06

Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer (1976) 1.06

Familial chronic lymphocytic leukemia. Ann Intern Med (1969) 1.06

In vivo and in vitro production of human chorionic gonadotropin and alpha-feteoprotein by a virilizing hepatoblastoma. J Clin Endocrinol Metab (1972) 1.04

Functional genomic analysis in arthritis-affected cartilage: yin-yang regulation of inflammatory mediators by alpha 5 beta 1 and alpha V beta 3 integrins. J Immunol (2000) 1.04

Hepatitis-associated antigen and antibody in Uganda: correlation of serological testing with histopathology. Br Med J (1972) 1.04

A rapid and effecient method for the isolation of proteins from polyacrylamide cells. Prep Biochem (1977) 1.04

Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer. J Natl Cancer Inst (1986) 1.02

Studies on levamisole--induced agranulocytosis. Blood (1980) 0.98

Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations. Cancer (1974) 0.97

Aspergillus lobar pneumonia. JAMA (1969) 0.97

Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. J Pain Symptom Manage (1991) 0.97

Purification and characterization of a human lung tumor-associated antigen. J Natl Cancer Inst (1978) 0.97

A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer (1975) 0.96

Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer. J Clin Oncol (1995) 0.96

A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines. Mol Cell Biol (1993) 0.95

Treatment of Kaposi's sarcoma with a combination of actinomycin D and vincristine. Results of a randomized clinical trial. Cancer (1973) 0.94

Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas. Cancer (1973) 0.94

Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains. J Clin Invest (1994) 0.94

A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-alpha A in Daudi cells. J Biol Chem (1989) 0.93

The use of a radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer (1974) 0.93

Sarcomas and multiple polyposis in a kindred. A genetic variety of hereditary polyposis? Arch Intern Med (1968) 0.92

Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning. Cancer Res (1980) 0.92

Burkitt's tumor in the United States. Cancer (1969) 0.92

Lambda Bence Jones proteins of the mouse: chemical and immunological characterization. J Mol Biol (1967) 0.92

Prolonged adjuvant stimulation in germ-free BALB-c mice: development of plasma cell neoplasia. Immunology (1969) 0.91

Effect of sustained diuresis on the renal lesions of mice with Bence Jones protein-producing tumors. J Lab Clin Med (1974) 0.91

Secretion of methotrexate into human milk. Am J Obstet Gynecol (1972) 0.90

Results of the second international study on the W.H.O. alpha-foetoprotein standard. J Biol Stand (1978) 0.90

Further studies on a human lung tumor-associated antigen. Comparison of antigens from different tumors. J Biol Chem (1979) 0.89

Immunological studies in Ugandan patients with hepatocellular carcinoma. Br Med J (1973) 0.89

Macroglobulin-producing plasma-cell tumor in mice: identification of a new light chain. Science (1965) 0.89

Adriamycin therapy in American patients with hepatocellular carcinoma. Cancer Treat Rep (1977) 0.89

Catalytic activity of the mouse guanine nucleotide exchanger mSOS is activated by Fyn tyrosine protein kinase and the T-cell antigen receptor in T cells. Proc Natl Acad Sci U S A (1996) 0.88

Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg (1998) 0.87

Enhanced suppression of experimental allergic encephalomyelitis by combination chemotherapy with duazomycin-A and 6-mercaptopurine. Proc Soc Exp Biol Med (1969) 0.86

Value of 8S/4S fractionation of estrogen receptors (ER) for prediction of response to hormonal manipulation in metastatic breast cancer. Breast Cancer Res Treat (1984) 0.86

Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities. Biochemistry (1997) 0.86

Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) Trial. Eur J Cancer (1992) 0.85

The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma. J Urol (1978) 0.85

Dopa and 5-S-cysteinyldopa in malignant melanoma in Ugandan Africans. Acta Derm Venereol (1974) 0.85

Immunologic markers of human bronchial epithelial cells in tissue sections and in culture. J Natl Cancer Inst (1979) 0.85

Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study. Cancer (1978) 0.85

Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project. J Clin Oncol (1984) 0.84

Modulation of interferon-alpha and interferon-gamma receptor expression during T-lymphocyte activation and proliferation. J Interferon Res (1986) 0.83

Elaboration of human chorionic gonadotropin by lung tumors: an immunocytochemical study. Arch Pathol Lab Med (1981) 0.83

Protocollagen proline hydroxylase in sera of Ugandans with hepatocellular carcinoma. J Natl Cancer Inst (1972) 0.83

Carcinogenicity of aflatoxin B1 in rhesus monkeys: two additional cases of primary liver cancer. J Natl Cancer Inst (1976) 0.83

Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer. J Natl Cancer Inst (1988) 0.83

Expression of IFN-alpha and IFN-gamma receptors on normal human small resting T lymphocytes and large granular lymphocytes. J Immunol (1986) 0.82

Ultrastructural survey of primary liver cell carcinomas from Uganda. J Natl Cancer Inst (1972) 0.82

Structural studies of a heavy chain from a mouse immunoglobulin M with antibody activity. J Biol Chem (1973) 0.82

Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative. Cancer Res (1969) 0.82

Genomic paradigms for food-borne enteric pathogen analysis at the USFDA: case studies highlighting method utility, integration and resolution. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2012) 0.82

Fetal hemoglobin and alpha-fetoprotein in various malignancies. Acta Haematol (1977) 0.82

Protein-A antibody-binding TPAAB) technique for detection of tumor-associated membrane antigen (TAMA) of Lewis lung carcinoma. Int J Cancer (1980) 0.82

Glutamate dehydrogenase activity related to histopathological grade of hepatocellular carcinoma in man. Cancer Res (1974) 0.82

17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1. Biochemistry (1994) 0.81

Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer. Natl Cancer Inst Monogr (1978) 0.81

Phase II study of oral etoposide for patients with advanced breast cancer. Cancer (1995) 0.81